CCNB2 and breast carcinoma: Moreover, CENPL was detected as one of the novel hub genes and served as a prognostic marker candidate in breast cancer [48], and high expression of CCNB2 in breast carcinoma showed an association with disadvantageous clinical outcomes [49].